| Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai–Dorfman disease SJ Simko, HD Tran, J Jones, M Bilgi, LK Beaupin, D Coulter, T Garrington, ... Pediatric blood & cancer 61 (3), 479-487, 2014 | 143 | 2014 |
| Prognostic significance of early lymphocyte recovery in pediatric osteosarcoma C Moore, D Eslin, A Levy, J Roberson, V Giusti, R Sutphin Pediatric blood & cancer 55 (6), 1096-1102, 2010 | 66 | 2010 |
| MicroRNAs in Ewing sarcoma L Dylla, C Moore, P Jedlicka Frontiers in oncology 3, 65, 2013 | 45 | 2013 |
| MiR-193b, downregulated in Ewing Sarcoma, targets the ErbB4 oncogene to inhibit anchorage-independent growth C Moore, JK Parrish, P Jedlicka PLoS One 12 (5), e0178028, 2017 | 25 | 2017 |
| A phase II study of vorinostat (NSC 701852) in patients (pts) with relapsed non-small cell lung cancer (NSCLC) AM Traynor, S Dubey, J Eickhoff, JM Kolesar, SM Marcotte, LC Hammes, ... Journal of Clinical Oncology 25 (18_suppl), 18044-18044, 2007 | 12 | 2007 |
| TRIM28 congenital predisposition to Wilms’ tumor: novel mutations and presentation in a sibling pair C Moore, H Monforte, JK Teer, Y Zhang, S Yoder, AS Brohl, DR Reed Molecular Case Studies 6 (4), a004796, 2020 | 8 | 2020 |
| B-cell acute lymphoblastic leukemia with high mutation burden presenting in a child with constitutional mismatch repair deficiency B Oshrine, N Grana, C Moore, J Nguyen, M Crenshaw, M Edwards, ... Blood Advances 3 (12), 1795-1798, 2019 | 8 | 2019 |
| Using log data to measure provider EHR activity at a cancer center during rapid telemedicine deployment C Moore, A Valenti, E Robinson, R Perkins Applied Clinical Informatics 12 (03), 629-636, 2021 | 7 | 2021 |
| Successful pulmonary artery embolectomy in a patient with a saddle Wilms tumor embolus L Cooper, C Moore, B Branchford, B Greffe, K Capocelli, A Kuder, I Mehta, ... Pediatric Blood & Cancer 58 (5), 806-809, 2012 | 5 | 2012 |
| Oncology providers' and professionals' experiences with suicide risk screening among patients with head and neck cancer: a qualitative study K Turner, AM Stover, DB Tometich, C Geiss, A Mason, OT Nguyen, ... JCO oncology practice 19 (6), e892-e903, 2023 | 2 | 2023 |
| Implementing digital scribes to reduce electronic health record documentation burden among cancer care clinicians: a mixed-methods pilot study OT Nguyen, K Turner, D Charles, O Sprow, R Perkins, YR Hong, JY Islam, ... JCO Clinical Cancer Informatics 7, e2200166, 2023 | 2 | 2023 |
| Engineering-Scale Batch Purification of Ternary MgCl2-KCl-NaCl Salt Using Thermal and Magnesium Contact Treatment KR Robb, S Baird, J Massengale, N Hoyt, J Guo, C Moore Oak Ridge National Lab.(ORNL), Oak Ridge, TN (United States), 2022 | 2 | 2022 |
| PROGNOSTIC SIGNIFICANCE OF EARLY LYMPHOCYTE RECOVERY IN PEDIATRIC OSTEOSARCOMA R Sutphin, C Moore PEDIATRIC BLOOD & CANCER 52 (6), 739-739, 2009 | 2 | 2009 |
| Examining disparities in large‐scale patient‐reported data capture using digital tools among cancer patients at clinical intake DE Rollison, BD Gonzalez, K Turner, HSL Jim, Y Zhao, RP Amorrortu, ... Cancer Medicine 12 (18), 19033-19046, 2023 | 1 | 2023 |
| Benign goiters requiring thyroidectomy as the signal for PTEN hamartoma tumor syndrome diagnosis X Wang, C Moore, Y Bao American Journal of Medical Genetics Part A 191 (3), 753-759, 2023 | 1 | 2023 |
| Identifying sources of burnout among clinicians at a cancer center: A qualitative analysis. O Nguyen, A Alishahi, CE Moore, R Perkins, J Bickel Young, D Heimbeck, ... Journal of Clinical Oncology 40 (28_suppl), 429-429, 2022 | | 2022 |
| Breaking Down the Barriers of Hereditary Cancer Risk Disclosure in AYA C Moore, DK Berry, KR Gewandter Pediatrics 150 (2), e2022057087, 2022 | | 2022 |
| GeneHome–a Novel Model to Deliver Care to Individuals with Genetic Predisposition to Cancer N Nocera Zachariah, MC Lee, MD Chang, C Moore, X Wang Cancer Control 29, 10732748221109951, 2022 | | 2022 |
| eP062: Clinically significant goiters as the initial presentation of PTEN hamartoma tumor syndrome V Tarasova, C Moore, Y Bao, X Wang Genetics in Medicine 24 (3), S40-S41, 2022 | | 2022 |
| CLOFARABINE USE IN REFRACTORY MULTIFOCAL BONE LANGERHANS CELL HISTIOCYTOSIS: A CASE REPORT C Moore, T Garrington PEDIATRIC BLOOD & CANCER 60 (9), E80-E80, 2013 | | 2013 |
